Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.07%
1,101.37
-0.81
-0.07%
—1,102.181,096.241,103.051,090.35——
SIXC
Communications
SIXC
Communications
SIXC
-0.47%
613.35
-2.89
-0.47%
—616.24616.24617.68609.10——
SIXE
Energy
SIXE
Energy
SIXE
+0.77%
1,198.83
+9.11
+0.77%
—1,189.721,194.741,202.791,188.58——
SIXI
Industrials
SIXI
Industrials
SIXI
+1.75%
1,755.95
+30.26
+1.75%
—1,725.691,730.021,762.991,730.02——
SIXM
Financials
SIXM
Financials
SIXM
-0.79%
638.51
-5.11
-0.79%
—643.62643.13643.17632.59——
SIXR
Staples
SIXR
Staples
SIXR
+1.65%
843.52
+13.73
+1.65%
—829.79832.32845.25832.32——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+1.19%
215.95
+2.55
+1.19%
—213.40213.40216.07213.40——
SIXT
Technology
SIXT
Technology
SIXT
-1.48%
3,138.91
-47.01
-1.48%
—3,185.923,160.893,178.723,102.60——
SIXU
Utilities
SIXU
Utilities
SIXU
+2.80%
934.37
+25.43
+2.80%
—908.94912.57934.91912.57——
SIXV
Health care
SIXV
Health care
SIXV
-0.10%
1,477.43
-1.53
-0.10%
—1,478.961,478.171,482.911,466.65——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-1.05%
2,380.19
-25.17
-1.05%
—2,405.362,390.342,402.532,359.18——
524715:BOM
Sun Pharmaceutical Industries Ltd
₹1,621.90
-3.45%
(-57.95) 1D
Apr 24, 12:10:01 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 524715...
Open
₹1,674.60
High
₹1,674.60
Low
₹1,619.05
Mkt. cap
3.89T
Avg. vol.
137.62K
Volume
220.21K
Dividend
1.02%
Quarterly dividend
₹4.13
Ex dividend date
Jul 7, 2025
P/E ratio
35.68
52-wk high
₹1,850.95
52-wk low
₹1,547.25
EPS
₹45.45
Shares outstanding
0.00
No. of employees
43K
News stories
From sources across the web
Profile
Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. It manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients in more than 100 countries. It is the largest pharmaceutical company in India and the fourth largest specialty generic pharmaceutical company in the world. Around 70% of Sun Pharma’s revenue is generated from international markets. The US and India are the largest markets, accounting for over 60% of the company's turnover. Manufacturing is across 43 locations in India, the US, Asia, Africa, Australia and Europe. The products cater to therapeutic segments covering psychiatry, anti-infectives, neurology, cardiology, diabetology, gastroenterology, ophthalmology, nephrology, urology, dermatology, gynaecology, respiratory, oncology, dental and nutritionals. Its active pharmaceutical products include baricitinib, brivaracetam, and dapaglifozin. Wikipedia
About Sun Pharmaceutical Industries Ltd
CEO-
Employees43K
Founded1983
HeadquartersGoregaon East, Mumbai, India
SectorPharmaceutical industry
Websitesunpharma.com
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
129.59B
138.51B
144.78B
155.21B
Cost of goods sold
34.48B
28.15B
29.83B
29.45B
Cost of revenue
34.48B
28.15B
29.83B
29.45B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
25.66B
28.02B
27.65B
28.92B
Operating expense
66.55B
76.65B
81.28B
85.13B
Total operating expenses
101.03B
104.79B
111.11B
114.58B
Operating income
28.56B
33.72B
33.67B
40.62B
Other non operating income
-12.90B
4.64B
4.70B
5.79B
EBT including unusual items
32.48B
31.63B
41.55B
42.07B
EBT excluding unusual items
30.98B
39.81B
41.55B
46.97B
Income tax expense
10.94B
8.70B
10.31B
8.26B
Effective tax rate
33.68%
27.51%
24.80%
19.63%
Other operating expenses
34.25B
41.62B
46.34B
48.89B
Net income
21.50B
22.79B
31.18B
33.69B
Net profit margin
16.59%
16.45%
21.54%
21.71%
Earnings per share
10.01
11.98
13.00
15.48
Interest and investment income
12.97B
-
-
-
Interest expense
-491.40M
-748.00M
-998.60M
-783.60M
Net interest expenses
12.48B
-748.00M
-998.60M
-783.60M
Depreciation and amortization charges
6.64B
7.01B
7.30B
7.32B
EBITDA
34.46B
39.63B
40.82B
46.53B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer